{"entity":{"type":"insider","cik":"0001808356","url":"/insider/0001808356","json_url":"/insider/0001808356.json","name":"Wilson Mark Andrew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":25,"first":"2020-05-20","last":"2025-11-25","span_basis":"filed_date"},"name_variants":[{"name":"Wilson Mark Andrew","source":"filing","n_filings":25,"first_seen":"2020-05-20","last_seen":"2025-11-25"}],"transactions":[{"id":4372661,"accession":"0001193125-25-297852","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-297852","line_url":"/filing/0001193125-25-297852#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":630.0,"shares_display":"630","price_per_share":54.28,"price_display":"54.28","price_state":"stated","total_value":34196.4,"total_display":"34,196.40","total_whole":"34,196","shares_owned_after":21585.0,"shares_owned_after_display":"21,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-25","scope":"insider"},{"id":4237102,"accession":"0000950170-25-110774","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-110774","line_url":"/filing/0000950170-25-110774#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":676.0,"shares_display":"676","price_per_share":26.59,"price_display":"26.59","price_state":"stated","total_value":17974.84,"total_display":"17,974.84","total_whole":"17,975","shares_owned_after":20312.0,"shares_owned_after_display":"20,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-19","filed_date":"2025-08-21","scope":"insider"},{"id":4377319,"accession":"0000950170-25-075977","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-075977","line_url":"/filing/0000950170-25-075977#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9996.0,"shares_display":"9,996","price_per_share":0.67,"price_display":"0.67","price_state":"stated","total_value":6697.32,"total_display":"6,697.32","total_whole":"6,697","shares_owned_after":314296.0,"shares_owned_after_display":"314,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-19","filed_date":"2025-05-21","scope":"insider"},{"id":4749064,"accession":"0000950170-25-025040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-025040","line_url":"/filing/0000950170-25-025040#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11040.0,"shares_display":"11,040","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":11150.4,"total_display":"11,150.40","total_whole":"11,150","shares_owned_after":324292.0,"shares_owned_after_display":"324,292","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"},{"id":2350900,"accession":"0000950170-24-140591","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-140591","line_url":"/filing/0000950170-24-140591#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16560.0,"shares_display":"16,560","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":14738.4,"total_display":"14,738.40","total_whole":"14,738","shares_owned_after":335332.0,"shares_owned_after_display":"335,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-24","filed_date":"2024-12-26","scope":"insider"},{"id":2350897,"accession":"0000950170-24-140591","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-140591","line_url":"/filing/0000950170-24-140591#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33402.0,"shares_display":"33,402","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":30061.8,"total_display":"30,061.80","total_whole":"30,062","shares_owned_after":351892.0,"shares_owned_after_display":"351,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-23","filed_date":"2024-12-26","scope":"insider"},{"id":3091004,"accession":"0000950170-24-129462","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-129462","line_url":"/filing/0000950170-24-129462#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6407.0,"shares_display":"6,407","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":6471.07,"total_display":"6,471.07","total_whole":"6,471","shares_owned_after":218856.0,"shares_owned_after_display":"218,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-20","scope":"insider"},{"id":2277020,"accession":"0000950170-24-099353","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-099353","line_url":"/filing/0000950170-24-099353#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5651.0,"shares_display":"5,651","price_per_share":1.28,"price_display":"1.28","price_state":"stated","total_value":7233.28,"total_display":"7,233.28","total_whole":"7,233","shares_owned_after":225263.0,"shares_owned_after_display":"225,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-20","scope":"insider"},{"id":2205115,"accession":"0000950170-24-062644","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-062644","line_url":"/filing/0000950170-24-062644#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6260.0,"shares_display":"6,260","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":10955.0,"total_display":"10,955.00","total_whole":"10,955","shares_owned_after":230414.0,"shares_owned_after_display":"230,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-17","filed_date":"2024-05-20","scope":"insider"},{"id":3018871,"accession":"0000950170-24-019044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-019044","line_url":"/filing/0000950170-24-019044#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7606.0,"shares_display":"7,606","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":5172.08,"total_display":"5,172.08","total_whole":"5,172","shares_owned_after":236674.0,"shares_owned_after_display":"236,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-22","scope":"insider"},{"id":8079382,"accession":"0001209191-23-056183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-056183","line_url":"/filing/0001209191-23-056183#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7179.0,"shares_display":"7,179","price_per_share":0.49,"price_display":"0.49","price_state":"stated","total_value":3517.71,"total_display":"3,517.71","total_whole":"3,518","shares_owned_after":243780.0,"shares_owned_after_display":"243,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-20","scope":"insider"},{"id":8334534,"accession":"0001209191-23-046461","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-046461","line_url":"/filing/0001209191-23-046461#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7221.0,"shares_display":"7,221","price_per_share":0.78,"price_display":"0.78","price_state":"stated","total_value":5632.38,"total_display":"5,632.38","total_whole":"5,632","shares_owned_after":250959.0,"shares_owned_after_display":"250,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-17","scope":"insider"},{"id":8723684,"accession":"0001209191-23-030447","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-030447","line_url":"/filing/0001209191-23-030447#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7543.0,"shares_display":"7,543","price_per_share":0.72,"price_display":"0.72","price_state":"stated","total_value":5430.96,"total_display":"5,430.96","total_whole":"5,431","shares_owned_after":257680.0,"shares_owned_after_display":"257,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-17","scope":"insider"},{"id":8605927,"accession":"0001209191-23-010954","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-010954","line_url":"/filing/0001209191-23-010954#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8275.0,"shares_display":"8,275","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":24825.0,"total_display":"24,825.00","total_whole":"24,825","shares_owned_after":265223.0,"shares_owned_after_display":"265,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-17","scope":"insider"},{"id":6278843,"accession":"0001209191-22-057967","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-057967","line_url":"/filing/0001209191-22-057967#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8690.0,"shares_display":"8,690","price_per_share":3.57,"price_display":"3.57","price_state":"stated","total_value":31023.3,"total_display":"31,023.30","total_whole":"31,023","shares_owned_after":272498.0,"shares_owned_after_display":"272,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-18","scope":"insider"},{"id":6149394,"accession":"0001209191-22-046488","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-046488","line_url":"/filing/0001209191-22-046488#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3189.0,"shares_display":"3,189","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":15179.64,"total_display":"15,179.64","total_whole":"15,180","shares_owned_after":281188.0,"shares_owned_after_display":"281,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-17","scope":"insider"},{"id":6373045,"accession":"0001209191-22-029904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-029904","line_url":"/filing/0001209191-22-029904#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3136.0,"shares_display":"3,136","price_per_share":3.95,"price_display":"3.95","price_state":"stated","total_value":12387.2,"total_display":"12,387.20","total_whole":"12,387","shares_owned_after":117939.0,"shares_owned_after_display":"117,939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-17","scope":"insider"},{"id":6750497,"accession":"0001209191-22-011441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-011441","line_url":"/filing/0001209191-22-011441#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3661.0,"shares_display":"3,661","price_per_share":10.95,"price_display":"10.95","price_state":"stated","total_value":40087.95,"total_display":"40,087.95","total_whole":"40,088","shares_owned_after":121075.0,"shares_owned_after_display":"121,075","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-16","filed_date":"2022-02-18","scope":"insider"},{"id":5209277,"accession":"0001209191-21-065225","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-065225","line_url":"/filing/0001209191-21-065225#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6564.0,"shares_display":"6,564","price_per_share":13.16,"price_display":"13.16","price_state":"stated","total_value":86382.24,"total_display":"86,382.24","total_whole":"86,382","shares_owned_after":86436.0,"shares_owned_after_display":"86,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-17","scope":"insider"},{"id":4426903,"accession":"0001209191-21-052393","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-052393","line_url":"/filing/0001209191-21-052393#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1910.0,"shares_display":"1,910","price_per_share":13.83,"price_display":"13.83","price_state":"stated","total_value":26415.3,"total_display":"26,415.30","total_whole":"26,415","shares_owned_after":72900.0,"shares_owned_after_display":"72,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-18","scope":"insider"},{"id":4937340,"accession":"0001209191-21-034190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034190","line_url":"/filing/0001209191-21-034190#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1917.0,"shares_display":"1,917","price_per_share":18.3,"price_display":"18.30","price_state":"stated","total_value":35081.1,"total_display":"35,081.10","total_whole":"35,081","shares_owned_after":74810.0,"shares_owned_after_display":"74,810","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-19","scope":"insider"},{"id":4138054,"accession":"0001209191-21-012124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-012124","line_url":"/filing/0001209191-21-012124#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2173.0,"shares_display":"2,173","price_per_share":22.37,"price_display":"22.37","price_state":"stated","total_value":48610.01,"total_display":"48,610.01","total_whole":"48,610","shares_owned_after":76727.0,"shares_owned_after_display":"76,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":4222247,"accession":"0001209191-21-007946","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-007946","line_url":"/filing/0001209191-21-007946#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5344.0,"shares_display":"5,344","price_per_share":19.45,"price_display":"19.45","price_state":"stated","total_value":103940.8,"total_display":"103,940.80","total_whole":"103,941","shares_owned_after":78900.0,"shares_owned_after_display":"78,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2021-02-04","scope":"insider"},{"id":2884039,"accession":"0001209191-20-059246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-059246","line_url":"/filing/0001209191-20-059246#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1539.0,"shares_display":"1,539","price_per_share":16.93,"price_display":"16.93","price_state":"stated","total_value":26055.27,"total_display":"26,055.27","total_whole":"26,055","shares_owned_after":49850.0,"shares_owned_after_display":"49,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-18","scope":"insider"},{"id":2587419,"accession":"0001209191-20-047619","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047619","line_url":"/filing/0001209191-20-047619#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1529.0,"shares_display":"1,529","price_per_share":19.67,"price_display":"19.67","price_state":"stated","total_value":30075.43,"total_display":"30,075.43","total_whole":"30,075","shares_owned_after":51389.0,"shares_owned_after_display":"51,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"},{"id":2179820,"accession":"0001209191-20-031017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-031017","line_url":"/filing/0001209191-20-031017#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001808356","owner_name":"Wilson Mark Andrew","owner_display_name":"Wilson Mark Andrew","owner_url":"/insider/0001808356","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1529.0,"shares_display":"1,529","price_per_share":22.51,"price_display":"22.51","price_state":"stated","total_value":34417.79,"total_display":"34,417.79","total_whole":"34,418","shares_owned_after":52418.0,"shares_owned_after_display":"52,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000906709","name":"NEKTAR THERAPEUTICS","url":"/issuer/0000906709","role":"Officer (Chief Legal Officer)","n_filings":25,"first_seen":"2020-05-20","last_seen":"2025-11-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001808356","retrieved_at":"2026-08-26T16:41:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}